CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in VYGR — Voyager Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in VYGR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$530,078
+$47,142 QoQ
Shares Held
151,451
+21.1% QoQ
Ownership
0.246%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 135 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. VYGR ranks #257 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in VYGR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $530,078 | 151,451 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $482,936 | 125,113 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $541,899 | 137,888 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $643,955 | 137,892 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $382,685 | 123,050 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $464,989 | 137,571 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $780,027 | 137,571 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $804,240 | 137,477 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,059,971 | 134,004 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,065,548 | 114,452 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $715,180 | 84,737 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $683,340 | 88,173 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $973,879 | 85,055 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $95,958 | 12,446 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $75,920 | 12,446 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $73,680 | 12,446 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $73,555 | 12,446 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $121,234 | 15,910 | Shares | Sole | 2022-05-13 | |
| 2021-06-30 | $471,877 | 114,256 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $776,580 | 164,879 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,214,713 | 169,890 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,784,312 | 167,227 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,103,476 | 166,678 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $1,885,833 | 206,102 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||